New policy addresses management liability needs unique to life sciences, biotech, and pharmaceutical firms and is specifically designed for the R&D ecosystem.
Commissioner Alan Kirkland said insurers "still have more work to do" to strengthen oversight of independent experts and improve their claims handling processes.